Archives for the 'news1' Category
Cynosure’s Smartlipo Gets CE Mark; U.S. Sales to Impact Second Quarter Results
For the morbidly obese (BMI > 40), liposuction is not really an option. But for a much broader set of women – those with fat deposits in ‘problem areas’ that respond poorly to diet and exercise – liposuction is a perfect fit.
And if you’re going the lipo route, one of the best options out there […]
Elemé Medical Raises $18 Million to Commercialize Cellulite Treatment
Treatment for cellulite is a healthcare holy grail – second only (in this author’s opinion) to a cure for male pattern baldness. As the bane of women the world over, interest in the space is hearty.
Elemé Medical has developed the FDA-cleared SmoothShapes system, a proprietary technology (dubbed Photomology) to treat the underlying causes of cellulite. […]
Urology Research Portal, Video from AUA 2008
In the past few months, we’ve featured a number of videos from the American Urological Association’s annual meeting (AUA 2008). The full catalog of content is now available at the recently launched Urology Channel. Check it out and let us know what you think.
Biolase Unveils More Affordable Dental Laser
Biolase Technology has launched a new hard and soft tissue laser for restorative general dentists, the Waterlase C100. The device is priced to appeal to a broader section of the dental market.
Based on market research, Jake St. Philip, Biolase CEO, believes a broader product offering to complements the company’s flagship Waterlase MD will increase adoption […]
Inovio Biomedical and VGX Pharmaceuticals to Merge
Citing synergies, Inovio Biomedical and VGX Pharmaceuticals have announced merger plans.
Inovio’s electroporation technology uses brief, controlled electrical pulses to increase cellular uptake of gene expression in DNA-based treatments; this enhances the potency of DNA-based immunotherapies against cancers and infectious diseases. Merging with VGX immediately adds a pipeline of DNA vaccine candidates and a team of […]
Despite Steady Progress, Applied NeuroSolutions Struggles
Applied NeuroSolutions (APNS), an IL-based firm developing products for the diagnosis and treatment of Alzheimer’s disease (AD), is struggling in penny stock land. Despite steady progress, APNS stock has declined, a trend that might have more to do with bear market skepticism and less with the company’s pipeline. As of March 31st, Applied had $2.5 […]
Monovisc Launch to Build Upon Orthovisc Success
Anika Therapeutics, a developer of products for tissue protection, healing and repair, announced that it has begun shipping Monovisc. The single-injection viscosupplement therapy is approved in Europe for treatment of osteoarthritis symptoms in all synovial joints.
Via Pubmed:
“Viscosupplementation therapy can restore the elastic and viscous properties of synovial fluid and thus recreate the intra-articular joint homeostasis […]
[Quick Take] Interview with Jeff Rencher, President of Sales & Marketing at Opticon Medical
Opticon Medical develops products for short-term urinary management and chronic urinary incontinence. The company has five FDA cleared products, including the Option-vf and Option-vm catheters highlighted in this video.
Option catheters use the body’s own bladder to store urine rather than a collection bag. When the bladder needs to be drained, the patient or caregiver activates […]
SAES Acquires Memry Corporation
Milan, Italy-based SAES has acquired Memry Corp. for $77.7 million or $2.51 per share. The price represents a premium of +/- 73% based on Memry’s closing price on June 23, 2008.
Memry develops nitinol-based and polymer-based medical device products, including its proprietary shape memory alloys. Medical device products include stent components, catheter components, guidewires, laparoscopic surgical […]
Bariatric Surgery Now Safer, Patient Database Reveals
The Michigan Bariatric Surgery Collaborative, a patient database funded by a $700,000 annual grant from Blue Cross Blue Shield of Michigan, sheds new light on the safety of bariatric surgery. [The statistics are the first in a three-year project and it may be too early to draw conclusions, warns David Share, a director of health […]
